Trials / Sponsors / Cortice Biosciences, Inc.
Cortice Biosciences, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avast Glioblastoma Multiforme | Phase 2 | 2014-01-01 |
| Suspended | Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Gliobla Glioblastoma Multiforme | Phase 1 / Phase 2 | 2013-08-01 |
| Terminated | A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2007-10-01 |
| Terminated | A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer Prostate Cancer | Phase 2 | 2007-01-01 |
| Completed | Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies Neoplasms, Hodgkin's Disease, Non-Hodgkin's Lymphoma | Phase 1 | 2005-11-01 |
| Completed | Study of TPI 287 in Patients With Advanced Malignancies Neoplasms, Non-Hodgkin Lymphoma, Hodgkin Disease | Phase 1 | 2005-05-01 |